Upregulation of FCGR3B in severe COVID-19 was validated in datasets from multiple tissue types including single-cell BALF, bulk PBMC and bulk nasopharyngeal data (Figures 3D, 3E, and 4A). Here, FCGR3B is linked to COVID-19.